EDP Sciences logo
Web of Conferences logo
Search
Menu
All issues Volume 210 (2020) E3S Web Conf., 210 (2020) 06017 References
Open Access
Issue
E3S Web Conf.
Volume 210, 2020
Innovative Technologies in Science and Education (ITSE-2020)
Article Number 06017
Number of page(s) 12
Section Livestock and Veterinary
DOI https://doi.org/10.1051/e3sconf/202021006017
Published online 04 December 2020
  1. N. T. Williams, “Probiotics.” American Journal of Health-System Pharmacy, 67(6), 449-458 (2010) [CrossRef] [Google Scholar]
  2. K. G. Rout, et al., “Benefaction of probiotics for human health: A review.” Journal of food and drug analysis, 26(3), 927-939 (2018) [CrossRef] [PubMed] [Google Scholar]
  3. A. N. Vlasova, et al., “Comparison of probiotic lactobacilli and bifidobacteria effects, immune responses and rotavirus vaccines and infection in different host species.” Veterinary immunology and immunopathology, 172, 72-84 (2016) [CrossRef] [PubMed] [Google Scholar]
  4. P. Markowiak, K. Śliżewska, “Effects of probiotics, prebiotics, and synbiotics on human health.” Nutrients, 9(9), 1021 (2017) [CrossRef] [Google Scholar]
  5. H.-J. Kang, S.-H. Im. “Probiotics as an immune modulator.” Journal of nutritional science and vitaminology, Supplement, 61, 103-105 (2015) [CrossRef] [Google Scholar]
  6. J. Villena, K. Haruki, “The modulation of mucosal antiviral immunity by Immunobiotics: could they offer any benefit in the SARS-CoV-2 pandemic?.” Frontiers in Physiology, 11 (2020) [CrossRef] [Google Scholar]
  7. L. Khailova, et al., “Bifidobacterium bifidum reduces apoptosis in the intestinal epithelium in necrotizing enterocolitis.” American Journal of Physiology-Gastrointestinal and Liver Physiology, 299(5), 1118-1127 (2010) [CrossRef] [Google Scholar]
  8. N. Saad, et al., “An overview of the last advances in probiotic and prebiotic field.” LWT-Food Science and Technology, 50(1), 1-16 (2013) [CrossRef] [Google Scholar]
  9. S.‐A. Esmaeili, et al., “Generation of tolerogenic dendritic cells using Lactobacillus rhamnosus and Lactobacillus delbrueckii as tolerogenic probiotics.” Journal of cellular biochemistry, 119(9), 7865-7872 (2018) [CrossRef] [PubMed] [Google Scholar]
  10. S. Balzaretti, et al., “A novel rhamnose-rich hetero-exopolysaccharide isolated from Lactobacillus paracasei DG activates THP-1 human monocytic cells.” Applied and environmental microbiology, 83(3) (2017) [CrossRef] [Google Scholar]
  11. K. Honda, R. L. Dan, “The microbiome in infectious disease and inflammation.” Annual review of immunology, 30, 759-795 (2012) [CrossRef] [PubMed] [Google Scholar]
  12. L.‐L. Zhang, et al., “Oral Bifidobacterium modulates intestinal immune inflammation in mice with food allergy.” Journal of gastroenterology and hepatology, 25(5), 928-934 (2010) [CrossRef] [PubMed] [Google Scholar]
  13. O. N. Donkor, et al. “Cytokine profile and induction of T helper type 17 and regulatory T cells by human peripheral mononuclear cells after microbial exposure.” Clinical & Experimental Immunology, 167(2), 282-295 (2012) [CrossRef] [Google Scholar]
  14. H.-K. Kwon, et al., “Generation of regulatory dendritic cells and CD4+ Foxp3+ T cells by probiotics administration suppresses immune disorders.” Proceedings of the National Academy of Sciences, 107(5), 2159-2164 (2010) [CrossRef] [Google Scholar]
  15. Md. Azad, et al., “Immunomodulatory effects of probiotics on cytokine profiles.” BioMed Research International 2018 (2018). [Google Scholar]
  16. H. P. Mykhal’chyshyn, P. M. Bodnar, N. M. Kobyliak, “Effect of probiotics on proinflammatory cytokines level in patients with type 2 diabetes and nonalcoholic fatty liver disease.” Likars’ ka sprava, 2, 56 (2013) [Google Scholar]
  17. C. M. Carey, K. Magdalena, “Lactic acid bacteria and bifidobacteria attenuate the proinflammatory response in intestinal epithelial cells induced by Salmonella enterica serovar Typhimurium.” Canadian Journal of Microbiology, 59(1), 9-17 (2013) [CrossRef] [PubMed] [Google Scholar]
  18. L. Giahi, et al., “Regulation of TLR4, p38 MAPkinase, IκB and miRNAs by inactivated strains of lactobacilli in human dendritic cells.” Beneficial microbes, 3(2), 91-98 (2012) [CrossRef] [PubMed] [Google Scholar]
  19. N. A. Castillo, P. Gabriela, de M. de LeB. Alejandra, “Oral administration of a probiotic Lactobacillus modulates cytokine production and TLR expression improving the immune response against Salmonella enterica serovar Typhimurium infection in mice.” BMC microbiology, 11(1), 177 (2011) [CrossRef] [PubMed] [Google Scholar]
  20. M. T. Abreu, “Toll-like receptor signalling in the intestinal epithelium: how bacterial recognition shapes intestinal function.” Nature Reviews Immunology, 10(2), 131-144 (2010) [CrossRef] [PubMed] [Google Scholar]
  21. J. M. Wells, “Immunomodulatory mechanisms of lactobacilli.” Microbial cell factories, 10(1) (BioMed Central, 2011) [CrossRef] [PubMed] [Google Scholar]
  22. M. Tohno, et al., “Immunobiotic Lactobacillus strains augment NLRP3 expression in newborn and adult porcine gut-associated lymphoid tissues.” Veterinary immunology and immunopathology, 144(3-4), 410-416 (2011) [CrossRef] [PubMed] [Google Scholar]
  23. N. Singh, et al., “Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis.” Immunity, 40(1), 128-139 (2014) [CrossRef] [PubMed] [Google Scholar]
  24. A. Murzyn, et al., “The effect of Saccharomyces boulardii on Candida albicans-infected human intestinal cell lines Caco-2 and Intestin 407.” FEMS microbiology letters, 310(1), 17-23 (2010) [CrossRef] [PubMed] [Google Scholar]
  25. R. B. Canani, et al., “Potential beneficial effects of butyrate in intestinal and extraintestinal diseases.” World journal of gastroenterology: WJG, 17(12), 1519 (2011) [CrossRef] [Google Scholar]
  26. F. Hirschhaeuser, G. A. S. Ulrike, M.-K. Wolfgang, “Lactate: a metabolic key player in cancer.” Cancer research, 71(22), 6921-6925 (2011) [CrossRef] [PubMed] [Google Scholar]
  27. O. R. Colegio, et al. “Functional polarization of tumour-associated macrophages by tumour-derived lactic acid.” Nature, 513(7519), 559-563 (2014) [CrossRef] [PubMed] [Google Scholar]
  28. M. T. Nieminen, et al., “DL-2-hydroxyisocaproic acid attenuates inflammatory responses in a murine Candida albicans biofilm model.” Clinical and Vaccine Immunology, 21(9), 1240-1245 (2014) [CrossRef] [Google Scholar]
  29. F. Yan, et al., “Colon-specific delivery of a probiotic-derived soluble protein ameliorates intestinal inflammation in mice through an EGFR-dependent mechanism.” The Journal of clinical investigation, 121(6), 2242-2253 (2011) [CrossRef] [PubMed] [Google Scholar]
  30. S. K. Tiwari, et al., “Probiotics at war against viruses: What is missing from the picture?.” Frontiers in Microbiology, 11, 1877 (2020) [CrossRef] [PubMed] [Google Scholar]
  31. J. Villena, et al., “Immunobiotics for the bovine host: their interaction with intestinal epithelial cells and their effect on antiviral immunity.” Frontiers in immunology, 9, 326 (2018) [CrossRef] [PubMed] [Google Scholar]
  32. J. Villena, et al., “Immunobiotics for the bovine host: their interaction with intestinal epithelial cells and their effect on antiviral immunity.” Frontiers in immunology, 9, 326 (2018) [CrossRef] [PubMed] [Google Scholar]
  33. V. Julio, M. G. Vizoso-Pinto, H. Kitazawa, “Intestinal innate antiviral immunity and immunobiotics: beneficial effects against rotavirus infection.” Frontiers in immunology, 7, 563 (2016) [PubMed] [Google Scholar]
  34. L. Ting, et al., “Local probiotic lactobacillus crispatus and lactobacillus delbrueckii exhibit strong antifungal effects against vulvovaginal candidiasis in a rat model.” Frontiers in Microbiology, 10, 1033 (2019) [CrossRef] [PubMed] [Google Scholar]
  35. S. Fukuda, et al., “Bifidobacteria can protect from enteropathogenic infection through production of acetate.” Nature, 469(7331), 543-547 (2011) [CrossRef] [PubMed] [Google Scholar]
  36. Y. Suda, et al., “Immunobiotic Lactobacillus jensenii as immune-health promoting factor to improve growth performance and productivity in post-weaning pigs.” BMC immunology, 15(1), 1-18 (2014) [CrossRef] [PubMed] [Google Scholar]
  37. T. Chiba, S. Hiroshi, “Indigenous clostridium species regulate systemic immune responses by induction of colonic regulatory T cells.” Gastroenterology, 141(3), 1114-1116 (2011) [CrossRef] [PubMed] [Google Scholar]
  38. S. Shigemori, S. Takeshi, “Applications of genetically modified immunobiotics with high immunoregulatory capacity for treatment of inflammatory bowel diseases.” Frontiers in immunology, 8, 22 (2017) [CrossRef] [PubMed] [Google Scholar]
  39. A. A. Khaskheli, et al., “A review on the influence of dietary immunobiotics on the performance, intestinal morphology and immune-related gene expression in post-hatched broiler chicks.” Aceh Journal of Animal Science, 5(1), 57-67 (2020) [Google Scholar]
  40. R. Marsella, S. Domenico, A. Kim, “Early exposure to probiotics in a canine model of atopic dermatitis has long-term clinical and immunological effects.” Veterinary immunology and immunopathology, 146(2), 185-189 (2012) [CrossRef] [PubMed] [Google Scholar]
  41. D. J. Thomas, et al., “Lactobacillus rhamnosus HN001 attenuates allergy development in a pig model.” PLoS One, 6(2), e16577 (2011) [CrossRef] [Google Scholar]
  42. J.-H. Shin, C. Myung-Jun, S. Jae-Gu, “A multistrain probiotic formulation attenuates skin symptoms of atopic dermatitis in a mouse model through the generation of CD4+ Foxp3+ T cells.” Food & nutrition research, 60(1), 32550 (2016) [CrossRef] [PubMed] [Google Scholar]
  43. X. Yang, et al., “Role of Lactobacillus in cervical cancer.” Cancer Management and Research, 10, 1219 (2018) [CrossRef] [PubMed] [Google Scholar]
  44. M. Mazanko, E. Prazdnova, D. Rudoy, A. Ermakov, A. Olshevskaya, T. Maltseva, E3S Web of Conferences, 175, 01010 (2020) INTERAGROMASH 2020 https://doi.org/10.1051/e3sconf/202017501010 [CrossRef] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.